Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Xuzhou
Clinical trial register · China

Clinical Trials in Xuzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19282 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:17 UTC
19282
Studies in scope
all four open statuses
11840
Recruiting now
open to new participants
2032
Lead sponsors
across recruiting studies
Top sites
Beijing 5606 Shanghai 3892 Guangzhou 3359 Hangzhou 1833 Wuhan 1342

Trials with a site in Xuzhou

134 of 19282 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Study on CD20 Monoclonal Antibody for Preventing Early EB Virus Activation After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07929974EBV Activation and EBV-PTLD After Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 2/3
214
Hefei, Zhengzhou, Huai'an, Nanjing, Xuzhou, Hangzhou, Beijing, Chongqing
2026-11
Not yet open
IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI
NCT07875179ST Elevation Myocardial Infarction (STEMI)
The Affiliated Hospital of Xuzhou Medical University
Phase 4
3,300
Xuzhou
2026-09-28
Not yet open
Peking University People's Hospital
Phase 4
200
Xuzhou
2026-09-20
Not yet open
Zhao Minghui
Phase 3
70
Fuzhou, Guangzhou, Harbin, Nanjing, Xuzhou, Nanchang, Shenyang, Yantai
2026-09-10
Not yet open
Shuangyue Liu
Not applicable
30
Hefei, Beijing, Nanjing, Xuzhou, Dalian, Shanghai, Xi’an, Chengdu
2026-09-07
Recruiting
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
NCT07764094PCI, Drug-coated Balloon, Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Observational
500
Chuzhou, Tongling, Huai'an, Lianyungang, Nanjing, Xuzhou, Yixing
2026-09-01
Not yet open
Haoran Feng
Not applicable
90
Xuzhou
2026-08-01
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
942
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
1,356
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
ShanShan Li
Observational
300
Shenzhen, Huai'an, Suzhou, Xuzhou, Dongying, Shanghai, Changzhou, Jiaozuo
2026-07-02
Not yet open
Guangdong Provincial People's Hospital
Observational
3,000
Chongqing, Guangzhou, Xuzhou, Hangzhou
2026-07
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
127
Beijing, Lanzhou, Guangzhou, Anyang, Luoyang, Zhengzhou, Nanjing, Xuzhou
2026-07
Not yet open
Shanghai Jiao Tong University School of Medicine
Phase 1/2
112
Xuzhou
2026-06-30
Not yet open
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Active, closed
Fructose for Acute Ischemic Stroke
NCT07626541Acute Ischemic Stroke
Ji Xunming,MD,PhD
Phase 2
46
Xuzhou
2026-06-05
Recruiting
A Phase I Study of JSKN021 in Advanced Solid Tumors
NCT07617727Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1
199
Fuzhou, Nanning, Harbin, Wuhan, Nanjing, Xuzhou, Jining, Shanghai
2026-06-02
Recruiting
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Active, closed
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
60
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Jinan, Hangzhou
2026-03-27
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Cangzhou, Kaifeng, Xuzhou, Zhenjiang, Xianyang, Jinan, Ningbo, Beijing
2026-03-23
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Not applicable
6
Xuzhou
2026-03-17
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Hefei, Shanghai, Guangzhou, Zhengzhou, Hangzhou, Nanjing, Xuzhou, Nanchang
2026-03-13
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 2
30
Xuzhou
2026-03-01
Not yet open
Shanghai Escugen Biotechnology Co., Ltd
Phase 2
40
Beijing, Xiamen, Guilin, Langfang, Changde, Changsha, Zhuzhou, Xuzhou
2026-03-01
Recruiting
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Not yet open
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2026-01-31
Recruiting
Nanjing Legend Biotech Co.
Phase 1
38
Bengbu, Guangzhou, Changsha, Xuzhou, Nanchang
2026-01-29
Not yet open
Fudan University
Phase 4
40
Xuzhou, Shanghai
2026-01-28
Recruiting
Shanghai Mental Health Center
Observational
121
Suzhou, Xuzhou, Shanghai, Hangzhou, Ningbo
2026-01-24
Recruiting
A Phase I Trial of A-CAR032 in Participants With mCRPC
NCT07344311Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Shanghai AbelZeta Ltd.
Phase 1
27
Beijing, Wuhan, Xuzhou, Hangzhou
2026-01-13
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Early Phase 1
38
Zhengzhou, Wuhan, Xuzhou, Nanchang, Beijing, Tianjin
2026-01-10
Recruiting
Shanghai SciBrunch Therapeutics Co., Ltd.
Phase 1/2
210
Hefei, Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Xuzhou, Shenyang
2026-01-08
Recruiting
Peking Union Medical College Hospital
Phase 2
158
Beijing, Nanjing, Xuzhou
2025-12-24
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
36
Zhengzhou, Nanjing, Xuzhou, Shanghai, Xi’an
2025-12-10
Recruiting
Eli Lilly and Company
Phase 2
60
Beijing, Chengdu, Guangzhou, Luoyang, Shanghai, Xuzhou
2025-12-08
Recruiting
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
180
Beijing, Fuzhou, Guangzhou, Harbin, Anyang, Zhengzhou, Xuzhou, Shenyang
2025-12-02
Recruiting
Kunming Pharmaceuticals, Inc.
Phase 2
300
Beijing, Shenzhen, Cangzhou, Hengshui, Daqing, Anyang, Nanyang, Xuzhou
2025-11-22
Not yet open
The Affiliated Hospital of Xuzhou Medical University
Phase 4
1,160
Fuyang, Huai'an, Lianyungang, Nanjing, Suqian, Xuzhou, Beijing, Shanghai
2025-11-20
Recruiting
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
NCT07236801Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Sjogren's Syndrome (SS), Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Xuzhou
2025-11-13
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
NCT07805967Multiple System Atrophy, Dementia With Lewy Bodies (DLB), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Second Affiliated Hospital of Soochow University
Observational
500
Changshu, Huai'an, Kunshan, Nanjing, Nantong, Suqian, Suzhou, Xuzhou
2025-11-12
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 1
12
Xuzhou
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Beijing, Guangzhou, Luoyang, Xuzhou, Nanchang, Wenzhou, Fuzhou, Jining
2025-10-03
Recruiting
The First Affiliated Hospital of Soochow University
Not applicable
224
Suzhou, Xuzhou, Hangzhou
2025-10-01
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Xuzhou, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-09-17
Recruiting
Capital Medical University
Phase 1/2
42
Xuzhou
2025-09-15
By invitation
Changchun BCHT Biotechnology Co.
Phase 1
80
Xuzhou
2025-09-13
Recruiting
Bambusa Therapeutics
Phase 1
68
Hefei, Guangzhou, Jiangmen, Qingyuan, Xinxiang, Yichang, Xuzhou, Nanchang
2025-09-05
Recruiting
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NCT07068438Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
210
Hefei, Beijing, Changzhou, Suzhou, Wuxi, Xuzhou, Nanchang, Hangzhou
2025-09-01
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Not applicable
50
Xuzhou
2025-09-01
Active, closed
a2 Milk Company Ltd.
Not applicable
100
Foshan, Guangzhou, Wuxi, Xuzhou, Chengdu
2025-08-25
Recruiting
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT07093411B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
Beijing GoBroad Hospital
Early Phase 1
48
Hefei, Xi'an, Xuzhou
2025-08-05
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 2
40
Xuzhou
2025-08-01
Not yet open
The Affiliated Hospital of Xuzhou Medical University
Observational
1,112
Xuzhou
2025-08
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
298
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Nanchang, Jinan
2025-07-30
Recruiting
DualityBio Inc.
Phase 2
750
Beijing, Dongguan, Henan, Xinxiang, Hubei, Wuhan, Changsha, Xuzhou
2025-07-18
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Beijing, Xuzhou, Changchun, Chengdu, Chongqing, Guangzhou, Hefei, Nanjing
2025-07-02
Not yet open
Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma
NCT07034755Multiple Myeloma (MM), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University
Not applicable
20
Xuzhou
2025-07-01
Active, closed
Shanghai Henlius Biotech
Phase 1
322
Xuzhou, Jiangsu
2025-06-04
Recruiting
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Not yet open
The Affiliated Hospital of Xuzhou Medical University
Not applicable
260
Xuzhou
2025-05-18
Not yet open
Xuzhou Medical University
Phase 2
60
Xuzhou
2025-05-01
Recruiting
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
National University of Singapore
Phase 4
600
Hangzhou, Xi'an, Xuzhou
2025-04-21
Recruiting
FBD Biologics Limited
Phase 1
50
Hangzhou, Xuzhou, Yantai, Zhujiang
2025-04-02
Recruiting
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
NCT07058103Angioimmunoblastic T-Cell Lymphoma Recurrent, Angioimmunoblastic T-Cell Lymphoma Refractory
The Affiliated Hospital of Xuzhou Medical University
Phase 2
40
Xuzhou
2025-04-01
Active, closed
The Affiliated Hospital of Xuzhou Medical University
Not applicable
18
Xuzhou
2025-03-18
Recruiting
BeOne Medicines
Phase 3
300
Beijing, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Xuzhou
2025-03-05
Not yet open
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Not yet open
Ying Gao
Observational
4,460
Lanzhou, Harbin, Zhengzhou, Nanjing, Xuzhou, Changchun, Jining, Xian
2025-03-01
Recruiting
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2024-12-31
Active, closed
Pulsed-Field Ablation With/Without Electrogram Mapping
NCT07541989Non-paroxysmal Atrial Fibrillation
Xu Liu
Not applicable
300
Wuhan, Changshu, Xuzhou, Jinan, Wenling, Yuhuan, Shanghai
2024-09-30
Recruiting
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
NCT06580301B-cell Acute Lymphoblastic Leukemia
DrugYK012
Excyte Biopharma Ltd
Phase 1/2
46
Guangzhou, Guiyang, Zhengzhou, Xuzhou, Nanchang, Changchun, Dalian, Shenyang
2024-09-25
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing, Xuzhou, Yancheng
2024-09-20
Recruiting
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
33
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
2024-09-19
Recruiting
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
NCT06615193Advanced Solid Tumors, Refractory Lymphoma, Relapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
111
Zhengzhou, Suzhou, Xuzhou, Nanchang, Jinan, Hangzhou, Tianjing
2024-08-12
Active, closed
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Active, closed
Xuzhou Medical University
Observational
5
Xuzhou
2024-08-01
Active, closed
The Affiliated Hospital of Xuzhou Medical University
Phase 3
150
Xuzhou
2024-08-01
Recruiting
Xintian Pharmaceutical
Phase 4
234
Chongqing, Xiamen, Guangzhou, Shenzhen, Shunde, Wuhan, Nanjing, Xuzhou
2024-07-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Observational
300
Xuzhou
2024-07-01
Recruiting
Juventas Cell Therapy Ltd.
Observational
200
Beijing, Guangzhou, Zhengzhou, Wuhan, Xuzhou, Jinan, Shanghai, Chengdu
2024-06-05
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NCT06118840Intracranial Aneurysm, CT Angiography, Deep Learning, Double Bind Interaction
Jinling Hospital, China
Not applicable
6,450
Hefei, Wuhu, Guiyang, Zhengzhou, Shiyan, Nanjing, Xuzhou, Changchun
2024-05-20
Active, closed
Hoffmann-La Roche
Observational
1,000
Shantou, Luoyang, Shiyan, Xuzhou, Fushun, Panjin, Shenyang, Weifang
2024-05-09
Recruiting
Grit Biotechnology
Not applicable
18
Beijing, Xuzhou
2024-04-18
Recruiting
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
NCT06316960AML, Childhood, Relapse/Recurrence, Refractory AML, Core Binding Factor Acute Myeloid Leukemia
Children's Hospital of Soochow University
Phase 2
50
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-03-01
Recruiting
RemeGen Co., Ltd.
Phase 2/3
90
Beijing, Xiamen, Harbin, Zhengzhou, Wuhan, Changsha, Xuzhou, Jinan
2024-02-22
Recruiting
Myasthenia Gravis Registry in China
NCT06241521Myasthenia Gravis
Huashan Hospital
Observational
1,500
Beijing, Chongqing, Guangzhou, Zhengzhou, Changsha, Suzhou, Xuzhou, Nanchang
2024-02-01
Recruiting
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2024-01-10
Recruiting
Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls
NCT06277466Type 2 Diabetes Mellitus, Gene Polymorphisms, Genetic Mutations, Susceptibility, Genetic
The Affiliated Hospital of Xuzhou Medical University
Not applicable
300
Xuzhou
2024-01-01
Recruiting
Children's Hospital of Soochow University
Phase 2
500
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-01-01
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Not applicable
300
Xuzhou
2024-01-01
Recruiting
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-12-25
Not yet open
Wen-hong Zhang
Observational
5,000
Hefei, Fuzhou, Wuhan, Nanjing, Xuzhou, Jinan, Taiyuan, Xi’an
2023-12-01
Recruiting
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-11-10
Recruiting
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
NCT06125652Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-11-04
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Early Phase 1
14
Xuzhou
2023-10-22
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Early Phase 1
14
Xuzhou
2023-10-22
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Hefei, Beijing, Zunyi, Wuhan, Xuzhou, Pingxiang, Shanghai, Zigong
2023-06-28
Recruiting
A Study of FZ-AD004 in Patients With Advanced Solid Tumors
NCT05914545Advanced and Metastatic Solid Tumor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 1
121
Hangzhou, Shanghai, Xuzhou
2023-06-21
Active, closed
The Affiliated Hospital of Xuzhou Medical University
Observational
500
Xuzhou
2023-05-01
Recruiting
Surgical-imaging Research on Obesity (SIRO)
NCT06268262Overweight and Obesity
The Affiliated Hospital of Xuzhou Medical University
Observational
200
Xuzhou
2023-03-01
Recruiting
Juventas Cell Therapy Ltd.
Phase 1/2
47
Hefei, Chongqing, Guangzhou, Wuhan, Nanjing, Xuzhou, Nanchang, Tianjin
2023-02-07
Recruiting
Beijing Airdoc Technology Co., Ltd.
Not applicable
304
Xuzhou
2022-12-12
Recruiting
Huashan Hospital
Observational
1,255
Lanzhou, Harbin, Hohhot, Suzhou, Xuzhou, Shenyang, Jinan, Jining
2022-12-01
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 1
20
Xuzhou
2022-12-01
Recruiting
MSD R&D (China) Co., Ltd.
Phase 1/2
203
Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xuzhou, Chengdu
2022-11-01
Active, closed
InxMed (Shanghai) Co., Ltd.
Phase 1/2
140
Hangzhou, Bengbu, Changsha, Fuzhou, Ganzhou, Nanjing, Wuhan, Xuzhou
2022-10-12
Active, closed
Bristol-Myers Squibb
Phase 2
34
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Shijiazhuang, Xuzhou, Shenyang
2022-08-19
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC
Phase 2
189
Beijing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Xuzhou, Nanchang, Chuangchun
2022-07-21
Active, closed
ArriVent BioPharma, Inc.
Phase 1
160
Hefei, Beijing, Chaoyang, Chongqing, Harbin, Zhengzhou, Wuhan, Xuzhou
2022-06-30
Recruiting
The Affiliated Hospital of Xuzhou Medical University
Phase 1/2
15
Xuzhou
2022-02-10
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
22
Beijing, Anyang, Luoyang, Xuzhou, Taiyuan, Suining
2021-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
153
Fuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Xuzhou, Changchun, Chengdu
2021-11-15
Active, closed
Nanfang Hospital, Southern Medical University
Observational
1,300
Chongqing, Guangzhou, Hebei, Changsha, Nanjing, Xuzhou, Nanchang, Changchun
2021-09-15
Recruiting
The GUARDIAN Trial
NCT04884802Blood Pressure
The University of Texas Health Science Center, Houston
Not applicable
6,254
Beijing, Chengdu, Hong Kong, Shanghai, Xuzhou
2021-07-25
Active, closed
Grit Biotechnology
Phase 1
12
Xuzhou
2021-04-21
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Beijing, Xicheng District, Lanzhou, Guangzhou, Haikou, Zhengzhou, Changsha, Xuzhou
2021-03-09
Active, closed
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718Heart Failure, Persistent Atrial Fibrillation
Xu Liu
Not applicable
300
Anqing, Wuhan, Changshu, Xuzhou, Jinan, Jining, Yuhuan, Shanghai
2021-01-01
Recruiting
Juventas Cell Therapy Ltd.
Phase 2
100
Beijing, Chongqing, Guangzhou, Sanhe, Zhengzhou, Wuhan, Xuzhou, Shanghai
2020-12-24
Recruiting
Epygenix
Phase 3
150
Beijing, Chongqing, Guangzhou, Shenzhen, Guiyang, Wuhan, Changsha, Xuzhou
2020-09-15
Active, closed
Xynomic Pharmaceuticals, Inc.
Phase 1/2
12
Beijing, Hangzhou, Tianjin, Xuzhou
2020-01-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Guangzhou, Zhanjiang, Zhengzhou, Changsha, Wuhan, Nanjing, Xuzhou, Nanchang
2019-10-02
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Recruiting
Beijing Hospital
Not applicable
115
Beijing, Guangzhou, Harbin, Nanjing, Xuzhou, Changchun, Xi'an, Luzhou
2019-07-02
Active, closed
SyMap Medical (Suzhou), Ltd.
Not applicable
160
Beijing, Guangzhou, Shenzhen, Shijiazhuang, Qiqihar, Nanjing, Suzhou, Xuzhou
2019-06-18
Recruiting
Xi Shan Wang
Observational
3,060
Shijiazhuang, Harbin, Wuhan, Changsha, Changzhou, Xuzhou, Yangzhou, Anshan
2018-11-02
Active, closed
Early CMR in Acute MI
NCT07602439Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Observational
2,000
Xuzhou
2018-10-31
Active, closed
SyMap Medical (Suzhou), Ltd.
Not applicable
220
Beijing, Chongqing, Shenzhen, Shijiazhuang, Daqing, Wuhan, Nanjing, Xuzhou
2016-06-30
Recruiting
Wei Zhao
Phase 4
1,500
Xuzhou, Tanjin
2016-01-31
Rows per page Showing 1–134 of 134
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-china/city/xuzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 15 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 134 of those studies with a site in Xuzhou.

How many clinical trials are recruiting in Xuzhou?

81 of the 134 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:17 UTC sync. A further 21 have not yet opened recruitment, 31 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xuzhou), 134 studies
PhaseStudiesRecruitingShare
Not applicable251518.7%
Phase 2221316.4%
Observational211115.7%
Phase 1/2201514.9%
Phase 1171112.7%
Phase 31369.7%
Phase 4946.7%
Early Phase 1543.7%
Phase 2/3221.5%

Most active sponsors

Lead sponsors with the most studies (Xuzhou)
Lead sponsorStudiesRecruiting
The Affiliated Hospital of Xuzhou Medical University2314
Xuzhou Medical University85
Hoffmann-La Roche52
Juventas Cell Therapy Ltd.33
Merck Sharp & Dohme LLC32
Shanghai Henlius Biotech30
Capital Medical University21
Children's Hospital of Soochow University22
Grit Biotechnology21
Huashan Hospital22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.